Skip to content

Flatiron Health at ASCO 2023. Learn more.

Enhanced Datamart

Our foundational data subscriptions, Enhanced Datamarts (EDMs), cover 22 tumor types and deliver a wide pool of clinical data sourced from electronic health records.

Accelerate oncology research with real-world evidence

Flatiron Enhanced Datamarts enable researchers to monitor and analyze key aspects of the patient journey. Sourced from the electronic health records of hundreds of thousands of patients in Flatiron’s OncoEMR, these curated, longitudinal, de-identified datasets contain a combination of structured and more sophisticated abstracted, derived, and extracted data elements for 22 different cancer types. 

EDMs are refreshed monthly with 30-day recency, allowing you to understand treatment journeys from diagnosis onward. 


22 disease-specific data models

EDMs for the following cancer types are currently available:
  • Acute myeloid leukemia
  • Early breast cancer
  • Metastatic breast cancer
  • Chronic lymphocytic leukemia
  • Metastatic colorectal cancer
  • Diffuse large B-Cell lymphoma
  • Advanced endometrial cancer
  • Follicular lymphoma
  • Advanced gastric/esophageal cancer
  • Advanced head and neck cancer
  • Hepatocellular carcinoma
  • Mantle cell lymphoma
  • Advanced melanoma
  • Multiple myeloma
  • Early non-small cell lung cancer
  • Advanced non-small cell lung cancer
  • Ovarian cancer
  • Metastatic pancreatic cancer
  • Metastatic prostate cancer
  • Metastatic renal cell carcinoma
  • Small cell lung cancer
  • Advanced urothelial carcinoma

Derive real-world endpoints using validated outcome variables


Real-world overall survival (rwOS)

Conduct robust survival analyses for studies with our validated mortality variable, available with all EDM subscriptions. 

See validation study


Real-world progression-free survival (rwPFS)

Analyze real-world progression-related endpoints across observational RWE studies with our validated real-world progression variable, available with certain EDM subscriptions. 

See validation study


Gain greater flexibility and address more use cases, in less time

If you have an evidence need that is not being met through your subscription offering, or don’t have the time or budget to design a fully customized project, consider Data on Demand. We have tailored our foundational data solution with a menu of optional custom add-ons including reason for therapy discontinuation for select drugs, comorbidities, additional malignancies, and more.

Explore more integrated real-world evidence products

Flatiron’s customizable real-world data products that integrate EHR-derived data with other data modalities.
Pattern C - Color Palette 1

Get in touch

Learn more about Enhanced Datamarts.